,
Smarter cancer care
Exact Sciences delivers the promise and value of precision medicine with the Oncotype IQ® portfolio of genomic tests.

Landmark RxPONDER Trial Results

Presented at the 2020 SABCS

Exact Sciences' Response to COVID-19

A Letter from our CEO, Kevin Conroy

Making cancer care smarter.™